FTAI Avaiation Stock Is a Sleeper Hit Among Winning Small-Cap Funds
A few small-cap fund managers are bucking a broader decadelong trend of losing to large-caps by betting on a handful of winning stocks. Small-cap stocks are in a deep slump. They have underperformed large caps seven of the past eight years. That trend is continuing this year, with small caps posting a gain of just
Pharma Investing Is All About Service Now. The Patent-Cliff Era Is Ending.
About the author: Molly McGaughan is managing director for North America at Beyond. For decades, investors have chosen pharma stocks based largely on which companies have drugs and vaccines being sold to large numbers of people. Savvy shareholders in these companies have worked to avoid looming “patent cliffs”—the moments when exclusivity on popular therapies runs